The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2023 | Early lung cancer at ELCC 2023
Samreen Ahmed, FRCP, MD, MBBS, MSc (onc), University Hospitals of Leicester, Leicester, UK, shares what she hopes to gain from the European Lung Cancer Congress (ELCC) 2023 in Copenhagen, Denmark, specifically, how the treatment of early lung cancer is being carried out globally. With emerging research highlighting the value of systemic treatment prior to surgery, the landscape of early lung cancer treatment is beginning to adjust accordingly. This interview took place at ELCC 2023 in Copenhagen, Denmark.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
